Delving into the Latest Updates on Encell Technology, Inc. with Synapse

概览

疾病领域	数量

神经系统疾病	1

排名前五的药物类型	数量

间充质干细胞疗法	1

关联

1

项与 Encell Technology, Inc. 相关的药物

EN-001 (Encell)

靶点-

作用机制

细胞替代物 [+1]

在研机构

Encell Technology, Inc.

原研机构

Encell Technology, Inc.

在研适应症

杜氏肌营养不良症 [+1]

非在研适应症-

最高研发阶段临床1/2期

首次获批国家/地区-

首次获批日期-

4

项与 Encell Technology, Inc. 相关的临床试验

NCT06328725 / Not yet recruiting临床1/2期

A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Trial to Evaluate the Efficacy and Safety of EN001 in Patients With Duchenne Muscular Dystrophy

A Multi-center, Randomized, Double-blind, Placebo-controlled, Phase 1/2 Trial to Evaluate the Efficacy and Safety of EN001 in Patients with Duchenne Muscular Dystrophy

开始日期2024-03-01

申办/合作机构

Encell Technology, Inc.

NCT06328712 / Recruiting临床1期

An Open, Dose-escalation, Phase 1b Clinical Trial to Evaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1A (CMT1A)

An Open, Dose-escalation, Phase 1b Clinical Trial to Evaluate the Safety and Efficacy of EN001 in Patients with Charcot-Marie-Tooth Disease type 1A (CMT1A)

开始日期2024-03-01

申办/合作机构

Encell Technology, Inc.

NCT05333406 / Completed临床1期

Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1A

Open-label, Dose-escalation, Phase 1 Clinical Trial to Determine the Safety and Dose of EN001 in Patients with Charcot-Marie-Tooth disease (CMT) type 1A

开始日期2022-02-22

申办/合作机构

Encell Technology, Inc.

100 项与 Encell Technology, Inc. 相关的临床结果

登录后查看更多信息

0 项与 Encell Technology, Inc. 相关的专利（医药）

登录后查看更多信息

100 项与 Encell Technology, Inc. 相关的药物交易

登录后查看更多信息

100 项与 Encell Technology, Inc. 相关的转化医学

登录后查看更多信息